Mga Batayang Estadistika
| CIK | 1824884 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Edoc Acquisition Corp.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39689 EDOC ACQUISITION CORP. (Exact name of registrant as specified in i |
|
| March 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 21, 2024 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 28, 2024 |
Exhibit 10.1 I-Bankers Securities, Inc. 535 5th Ave Suite 423 New York, New York 10017 Attn.: Mike McCrory, Chief Executive Officer March 21, 2024 Ladies and Gentlemen: Reference is made to the letter agreement, dated November 9, 2020, by and among, Edoc Acquisition Corp., a Cayman Islands exempted company (the “Company”), American Physicians LLC, a Delaware limited liability company (the “Sponsor |
|
| March 22, 2024 |
Adoc-form25 |
|
| March 11, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 5, 2024 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fil |
|
| March 8, 2024 |
Filed by Australian Oilseeds Holdings Limited Filed by Australian Oilseeds Holdings Limited Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: EDOC Acquisition Corp. |
|
| March 7, 2024 |
Filed by EDOC Acquisition Corp. Filed by EDOC Acquisition Corp. pursuant to Rule 425 under the U.S. Securities Act of 1933, as amended, under the Securities Exchange Act of 1934, as amended Subject Company: EDOC Acquisition Corp. Commission File No.: 001-39689 Date: March 7, 2024 On March 7, 2024, Kevin Chen, the Chief Executive Officer of EDOC Acquisition Corp. (“EDOC”), which is a party to a previously disclosed Business Combi |
|
| March 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| March 1, 2024 |
ORDINARY SHARES PURCHASE WARRANT AUSTRALIAN OILSEEDS HOLDINGS LIMITED Exhibit 10.4 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| March 1, 2024 |
AMENDMENT NO. 3 TO SECURITIES PURCHASE AGREEMENT Exhibit 10.1 AMENDMENT NO. 3 TO SECURITIES PURCHASE AGREEMENT This Amendment No. 3 to Securities Purchase Agreement (this “Amendment”) is made and entered into as of February 29, 2024 (the “Effective Date”), by and among Australian Oilseeds Holdings Limited, an exempted company incorporated in the Cayman Islands (the “Company”), EDOC Acquisition Corp., an exempted company incorporated in the Cayma |
|
| March 1, 2024 |
10% ORIGINAL ISSUE DISCOUNT SECURED CONVERTIBLE DEBENTURE DUE __________ 20251 Exhibit 10.3 EXHIBIT A-2 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFF |
|
| March 1, 2024 |
10% ORIGINAL ISSUE DISCOUNT SECURED CONVERTIBLE DEBENTURE DUE __________ 20251 Exhibit 10.3 EXHIBIT A-2 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFF |
|
| March 1, 2024 |
10% ORIGINAL ISSUE DISCOUNT SECURED CONVERTIBLE DEBENTURE DUE __________ 20251 Exhibit 10.2 EXHIBIT A-1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFF |
|
| March 1, 2024 |
10% ORIGINAL ISSUE DISCOUNT SECURED CONVERTIBLE DEBENTURE DUE __________ 20251 Exhibit 10.2 EXHIBIT A-1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFF |
|
| March 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 1, 2024 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fil |
|
| March 1, 2024 |
ORDINARY SHARES PURCHASE WARRANT AUSTRALIAN OILSEEDS HOLDINGS LIMITED Exhibit 10.4 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| March 1, 2024 |
AMENDMENT NO. 3 TO SECURITIES PURCHASE AGREEMENT Exhibit 10.1 AMENDMENT NO. 3 TO SECURITIES PURCHASE AGREEMENT This Amendment No. 3 to Securities Purchase Agreement (this “Amendment”) is made and entered into as of February 29, 2024 (the “Effective Date”), by and among Australian Oilseeds Holdings Limited, an exempted company incorporated in the Cayman Islands (the “Company”), EDOC Acquisition Corp., an exempted company incorporated in the Cayma |
|
| March 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 1, 2024 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| February 27, 2024 |
Exhibit 99.1 EDOC ACQUISITION CORP. ANNOUNCES POSTPONEMENT OF SPECIAL MEETING OF SHAREHOLDERS ON PROPOSED BUSINESS COMBINATION Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) - EDOC Acquisition Corp. (Nasdaq: ADOC) (“EDOC”) announced today that it has postponed its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was re-schedu |
|
| February 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 26, 2024 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| February 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 26, 2024 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| February 27, 2024 |
Exhibit 99.1 EDOC ACQUISITION CORP. ANNOUNCES POSTPONEMENT OF SPECIAL MEETING OF SHAREHOLDERS ON PROPOSED BUSINESS COMBINATION Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) - EDOC Acquisition Corp. (Nasdaq: ADOC) (“EDOC”) announced today that it has postponed its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was re-schedu |
|
| February 26, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 23, 2024 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| February 26, 2024 |
Exhibit 99.1 EDOC ACQUISITION CORP. ANNOUNCES POSTPONEMENT OF SPECIAL MEETING OF STOCKHOLDERS ON PROPOSED BUSINESS COMBINATION Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) - EDOC Acquisition Corp. (Nasdaq: ADOC) (“EDOC”) announced today that it has postponed its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was scheduled |
|
| February 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 23, 2024 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| February 26, 2024 |
Exhibit 99.1 EDOC ACQUISITION CORP. ANNOUNCES POSTPONEMENT OF SPECIAL MEETING OF STOCKHOLDERS ON PROPOSED BUSINESS COMBINATION Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) - EDOC Acquisition Corp. (Nasdaq: ADOC) (“EDOC”) announced today that it has postponed its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was scheduled |
|
| February 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| February 14, 2024 |
ADOC / Edoc Acquisition Corp. / Meteora Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Schedule 13/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 13, 2024 |
ADOC / Edoc Acquisition Corp. / GLAZER CAPITAL, LLC Passive Investment SC 13G/A 1 adoc20231231.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 EDOC ACQUISITION CORP. (Name of Issuer) Class A Ordinary Shares, $0.0001 par value per share (Title of Class of Securities) G4000A102 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriat |
|
| February 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 13, 2024 (February 12, 2024) EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorp |
|
| February 13, 2024 |
PROMISSORY NOTE Dated as of February 12, 2024 Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| February 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 13, 2024 (February 12, 2024) EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorp |
|
| February 13, 2024 |
PROMISSORY NOTE Dated as of February 12, 2024 Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| February 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 7, 2024 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| February 8, 2024 |
Exhibit 99.1 Australian Oilseeds and EDOC Acquisition Corp. Announce Effectiveness of Registration Statement and Date of Shareholder Meeting to Approve Proposed Business Combination ~ Shareholder Meeting of EDOC Acquisition Corp. to Approve Business Combination Scheduled for February 26, 2024 ~ ~ EDOC Shareholders of Record as of February 2, 2024, are Eligible to Vote at Meeting ~ ~ Upon Closing, |
|
| February 8, 2024 |
Exhibit 99.1 Australian Oilseeds and EDOC Acquisition Corp. Announce Effectiveness of Registration Statement and Date of Shareholder Meeting to Approve Proposed Business Combination ~ Shareholder Meeting of EDOC Acquisition Corp. to Approve Business Combination Scheduled for February 26, 2024 ~ ~ EDOC Shareholders of Record as of February 2, 2024, are Eligible to Vote at Meeting ~ ~ Upon Closing, |
|
| February 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| February 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 7, 2024 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| February 8, 2024 |
Filed by Australian Oilseeds Holdings Limited Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: EDOC Acquisition Corp. |
|
| January 31, 2024 |
SCHEDULE 13G CUSIP No. G4000A102 Page 11 of 11 Pages EX-99.1 SCHEDULE 13G CUSIP No. G4000A102 Page 11 of 11 Pages EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Units of EDOC Acquisition Corp. dated as of January 31, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and i |
|
| January 31, 2024 |
ADOC / Edoc Acquisition Corp. / Harraden Circle Investments, LLC - SC 13G/A Passive Investment SC 13G/A 1 d662214dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* EDOC Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) G4000A102 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statem |
|
| December 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 4, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| December 7, 2023 |
SECOND AMENDMENT TO BUSINESS COMBINATION AGREEMENT Exhibit 2.1 Execution Version SECOND AMENDMENT TO BUSINESS COMBINATION AGREEMENT This Second Amendment (“Second Amendment”) to the Business Combination Agreement (as defined below) is made and entered into as of December 7, 2023, by and among (i) Edoc Acquisition Corp, a Cayman Islands exempted company (together with its successors, the “Purchaser”), (ii) American Physicians LLC, a Delaware limite |
|
| December 7, 2023 |
Exhibit 2.1 Execution Version SECOND AMENDMENT TO BUSINESS COMBINATION AGREEMENT This Second Amendment (“Second Amendment”) to the Business Combination Agreement (as defined below) is made and entered into as of December 7, 2023, by and among (i) Edoc Acquisition Corp, a Cayman Islands exempted company (together with its successors, the “Purchaser”), (ii) American Physicians LLC, a Delaware limite |
|
| December 7, 2023 |
AMENDMENT NO. 2 TO SECURITIES PURCHASE AGREEMENT Exhibit 10.2 AMENDMENT NO. 2 TO SECURITIES PURCHASE AGREEMENT This Amendment No. 2 to Securities Purchase Agreement (this “Amendment”) is made and entered into as of December 4, 2023 (the “Effective Date”), by and among Australian Oilseeds Holdings Limited, an exempted company incorporated in the Cayman Islands (the “Company”), EDOC Acquisition Corp., an exempted company incorporated in the Cayman |
|
| December 7, 2023 |
Exhibit 10.2 AMENDMENT NO. 2 TO SECURITIES PURCHASE AGREEMENT This Amendment No. 2 to Securities Purchase Agreement (this “Amendment”) is made and entered into as of December 4, 2023 (the “Effective Date”), by and among Australian Oilseeds Holdings Limited, an exempted company incorporated in the Cayman Islands (the “Company”), EDOC Acquisition Corp., an exempted company incorporated in the Cayman |
|
| December 7, 2023 |
AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT Exhibit 10.1 AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT This Amendment No. 1 to Securities Purchase Agreement (this “Amendment”) is made and entered into as of October 31, 2023 (the “Effective Date”), by and among Australian Oilseeds Holdings Limited, an exempted company incorporated in the Cayman Islands (the “Company”), EDOC Acquisition Corp., an exempted company incorporated in the Cayman |
|
| December 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 4, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| December 7, 2023 |
Exhibit 10.1 AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT This Amendment No. 1 to Securities Purchase Agreement (this “Amendment”) is made and entered into as of October 31, 2023 (the “Effective Date”), by and among Australian Oilseeds Holdings Limited, an exempted company incorporated in the Cayman Islands (the “Company”), EDOC Acquisition Corp., an exempted company incorporated in the Cayman |
|
| December 6, 2023 |
Exhibit 99.1 Edoc Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q Victor, NY, Dec. 06, 2023 (GLOBE NEWSWIRE) - Edoc Acquisition Corp. (NASDAQ: ADOC) (the “Company”) announced that it received a letter from The Nasdaq Capital Market (“Nasdaq”) on November 30, 2023 indicating that (i) the Company’s failure to file its Quarterly Report |
|
| December 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 30, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| December 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39689 EDOC ACQUISI |
|
| November 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 28, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| November 28, 2023 |
Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| November 16, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition P |
|
| November 13, 2023 |
Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| November 13, 2023 |
Exhibit 3.1 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES SIXTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF EDOC ACQUISITION CORP. (ADOPTED BY SPECIAL RESOLUTION PASSED ON 6 NOVEMBER 2023) THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES SIXTH AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF EDOC ACQUISITION CORP. ( |
|
| November 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 27, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| November 3, 2023 |
Exhibit 10.1 ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT (WARRANT AGREEMENT) This ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT (this “Agreement”) is made as of October 27, 2023, by and among EDOC Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Warrant Agent”). WHEREAS, the Company and the Warran |
|
| November 3, 2023 |
Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 27, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| November 3, 2023 |
Exhibit 10.1 ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT (WARRANT AGREEMENT) This ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT (this “Agreement”) is made as of October 27, 2023, by and among EDOC Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Warrant Agent”). WHEREAS, the Company and the Warran |
|
| October 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| October 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| September 26, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 26, 2023 (September 25, 2023) EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of inco |
|
| August 24, 2023 |
Form of Pubco Secured Convertible Debenture Exhibit 10.2 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIS |
|
| August 24, 2023 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REG |
|
| August 24, 2023 |
Exhibit 10.2 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIS |
|
| August 24, 2023 |
Exhibit 99.1 Arena Investors, Australian Oilseeds Holdings Limited and EDOC Acquisition Corp. Announce an Investment of up to $7 Million and Plans for a $50 Million ELOC NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) - Arena Investors, LP (“Arena”), a $3.5 billion institutional asset manager, has entered into an agreement with Australian Oilseeds Holdings Limited (“Australian Oilseeds” or “Pubco”), whic |
|
| August 24, 2023 |
Exhibit 10.1 Execution Version SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of August 23, 2023, between Australian Oilseeds Holdings Limited, an exempted company incorporated in the Cayman Islands (the “Company”), EDOC Acquisition Corp., an exempted company incorporated in the Cayman Islands (“EDOC”), Australian Oilseeds Investments Pty Ltd., an A |
|
| August 24, 2023 |
Exhibit 10.1 Execution Version SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of August 23, 2023, between Australian Oilseeds Holdings Limited, an exempted company incorporated in the Cayman Islands (the “Company”), EDOC Acquisition Corp., an exempted company incorporated in the Cayman Islands (“EDOC”), Australian Oilseeds Investments Pty Ltd., an A |
|
| August 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 23, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission F |
|
| August 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 23, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission F |
|
| August 24, 2023 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REG |
|
| August 24, 2023 |
Exhibit 99.1 Arena Investors, Australian Oilseeds Holdings Limited and EDOC Acquisition Corp. Announce an Investment of up to $7 Million and Plans for a $50 Million ELOC NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) - Arena Investors, LP (“Arena”), a $3.5 billion institutional asset manager, has entered into an agreement with Australian Oilseeds Holdings Limited (“Australian Oilseeds” or “Pubco”), whic |
|
| August 16, 2023 |
Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| August 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 10, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission F |
|
| August 16, 2023 |
Fifth Amended and Restated Memorandum and Articles of Association of the Company Exhibit 3.1 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF EDOC ACQUISITION CORP. (ADOPTED BY SPECIAL RESOLUTION PASSED ON AUGUST 10 2023) THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES FIFTH AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF EDOC ACQUISITION CORP. (A |
|
| August 16, 2023 |
Amendment No. 1 to Rights Agreement, dated August 15, 2023 Exhibit 10.2 AMENDMENT NO. 1 TO RIGHTS AGREEMENT between EDOC ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY THIS AMENDMENT NO. 1 TO RIGHTS AGREEMENT (this “Amendment”), dated as of August 15, 2023, is by and between Edoc Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as rights agent (t |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39689 EDOC ACQUISITION |
|
| July 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| July 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 30, 2023 |
Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 26, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fil |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39689 EDOC ACQUISITION |
|
| May 1, 2023 |
Exhibit 10.1 THIS PROMISSORY NOTE ("NOTE") HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 25, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 6, 2023 |
425 1 ea176633-8kedocacqui.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other |
|
| April 6, 2023 |
Exhibit 2.1 AMENDMENT TO BUSINESS COMBINATION AGREEMENT This Amendment (“Amendment”) to the Business Combination Agreement (as defined below) is made and entered into as of March 31, 2023, by and among (i) Edoc Acquisition Corp, a Cayman Islands exempted company (together with its successors, the “Purchaser”), (ii) American Physicians LLC, a Delaware limited liability company, in the capacity as t |
|
| April 6, 2023 |
First Amendment to the Business Combination Agreement, dated as of March 31, 2023 Exhibit 2.1 AMENDMENT TO BUSINESS COMBINATION AGREEMENT This Amendment (“Amendment”) to the Business Combination Agreement (as defined below) is made and entered into as of March 31, 2023, by and among (i) Edoc Acquisition Corp, a Cayman Islands exempted company (together with its successors, the “Purchaser”), (ii) American Physicians LLC, a Delaware limited liability company, in the capacity as t |
|
| March 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 7, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* EDOC Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, $0.0001 par value (Title of Class of Securities) G4000A102 (CUSIP Number) NICHOLAS SABATINI, CFO & CCO; 1555 POST ROAD EAST, SUITE 202, WESTPORT, CT 06880; (203) 341-0702 (Name, Address and |
|
| February 16, 2023 |
EX-99.1 2 adocex9901.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regula |
|
| February 16, 2023 |
SC 13G/A 1 adoc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* EDOC Acquisition Corporation (Name of Issuer) Class A Ordinary share, $0.0001 par value (Title of Class of Securities) G4000A102 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Che |
|
| February 15, 2023 |
Form of Fourth Amended and Restated Memorandum and Articles of Association of the Company Exhibit 3.1 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES FOURTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF EDOC ACQUISITION CORP. (ADOPTED BY SPECIAL RESOLUTION PASSED ON February 9 2023) THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES FOURTH AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF EDOC ACQUISITION CORP. |
|
| February 15, 2023 |
SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* EDOC Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) G4000A102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| February 15, 2023 |
SCHEDULE 13G CUSIP No. G4000A102 Page 11 of 11 Pages EX-99.1 SCHEDULE 13G CUSIP No. G4000A102 Page 11 of 11 Pages EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Units of EDOC Acquisition Corp. dated as of February 14, 2023 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and |
|
| February 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| February 15, 2023 |
Exhibit 10.1 THIS PROMISSORY NOTE ("NOTE") HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| February 14, 2023 |
EDOC / Global X Telemedicine & Digital Health ETF / GLAZER CAPITAL, LLC Passive Investment SC 13G 1 adoc20221231.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 EDOC Acquisition Corporation (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G4000A102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropri |
|
| February 14, 2023 |
Joint Filing Agreement, by and between the Reporting Persons. EX-99.1 2 ea173578ex99-1edocacq.htm JOINT FILING AGREEMENT, BY AND BETWEEN THE REPORTING PERSONS Exhibit 99.1 JOINT FILING AGREEMENT AGREEMENT dated as of February 14, 2023 by and between American Physicians LLC, a Delaware limited liability company, and Xiaoping Becky Zhang (together, the “Parties”). Each Party hereto represents to the other Party that it is eligible to use Schedule 13D to report |
|
| February 14, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Edoc Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, $0.0001 par value (Title of Class of Securities) G4000A102 (CUSIP Number) Kevin Chen Chief Executive Officer 7612 Main Street Fishers, Suite 200 Victor, NY 14564 Telephone: (585) 678-1198 (Name, Address |
|
| February 13, 2023 |
SC 13G/A 1 d438983dsc13ga.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Edoc Acquisition Corp (Name of Issuer) Class A Ordinary Shares, $.0001 par value per share (Title of Class of Securities) G4000A102 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this |
|
| February 1, 2023 |
SC 13G/A 1 lfsc13gz.htm SCHEDULE 13G/A OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number:3235-0145 Expires:Febuary 28, 2009 Estimated average burden hours per response ....10.4 SCHEDULE 13G Under the Securities and Exchange Act of 1934 (Amendment No. 2 )* EDOC Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $ 0.0001 (Title of Clas |
|
| January 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* EDOC Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, $0.0001 par value (Title of Class of Securities) G4000A102 (CUSIP Number) NICHOLAS SABATINI, CFO & CCO; 1555 POST ROAD EAST, SUITE 202, WESTPORT, CT 06880; (203) 341-0702 (Name, Address and |
|
| January 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| January 25, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* EDOC Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G4000A102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| January 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39689 Edoc Acquisition |
|
| January 13, 2023 |
Edoc Acquisition Corp. 7612 Main Street Fishers Suite 200 Victor, NY 14564 Edoc Acquisition Corp. 7612 Main Street Fishers Suite 200 Victor, NY 14564 January 12, 2023 Via EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Edoc Acquisition Corp. Request for Withdrawal of Registration Statement on Form S-4 File No. 333-263628 Ladies and Gentlemen: Pursuant to Rule 477 under the Securities Act of 1933, a |
|
| January 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 10, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| January 13, 2023 |
Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| January 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 5, 2023 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission F |
|
| January 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| December 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 12, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorpo |
|
| December 27, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 20, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| December 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 5, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| December 9, 2022 |
Exhibit 2.1 Execution Version CONFIDENTIAL BUSINESS COMBINATION AGREEMENT by and among EDOC ACQUISITION CORP, as Purchaser, AMERICAN PHYSICIANS LLC, in the capacity as the Purchaser Representative, AUSTRALIAN OILSEEDS HOLDINGS LIMITED, as Pubco, AOI MERGER SUB, as Merger Sub, AUSTRALIAN OILSEEDS INVESTMENTS PTY LTD., as the Company, GARY SEATON in the capacity as the Seller Representative and THE |
|
| December 9, 2022 |
Exhibit 10.4 Execution Version FIRST AMENDMENT TO LETTER AGREEMENT THIS FIRST AMENDMENT TO LETTER AGREEMENT (this ?Amendment?) is made and entered into as of December 5, 2022, by and among (i) EDOC Acquisition Corp., a Cayman Islands exempted company (the ?Company?), (ii) Australian Oilseeds Investments Pty Ltd., an Australian private company (?AOI?), (iii) Australian Oilseeds Holdings Limited, up |
|
| December 9, 2022 |
Form of Non-Competition and Non-Solicitation Agreement, dated as of December 5, 2022. Exhibit 10.2 Final Form FORM OF NON-COMPETITION AND NON-SOLICITATION AGREEMENT THIS NON-COMPETITION AND NON-SOLICITATION AGREEMENT (this ?Agreement?) is being executed and delivered as of December 5, 2022, by the undersigned security holder of the Company (as defined below) (the ?Subject Party?) in favor of and for the benefit of Australian Oilseeds Holdings Limited, upon execution of a joinder ag |
|
| December 9, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 5, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| December 9, 2022 |
Form of Lock-Up Agreement, dated as of December 5, 2022. Exhibit 10.1 Final Form FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this ?Agreement?) is made and entered into as of December 5, 2022, by and among (i) Australian Oilseeds Holdings Limited, upon execution of a joinder agreement to become party to this Agreement (a ?Joinder?), a to-be-formed Cayman Islands exempted company (?Pubco?), (ii) American Physicians LLC, a Delaware limited liability |
|
| December 9, 2022 |
Exhibit 10.4 Execution Version FIRST AMENDMENT TO LETTER AGREEMENT THIS FIRST AMENDMENT TO LETTER AGREEMENT (this ?Amendment?) is made and entered into as of December 5, 2022, by and among (i) EDOC Acquisition Corp., a Cayman Islands exempted company (the ?Company?), (ii) Australian Oilseeds Investments Pty Ltd., an Australian private company (?AOI?), (iii) Australian Oilseeds Holdings Limited, up |
|
| December 9, 2022 |
Exhibit 2.1 Execution Version CONFIDENTIAL BUSINESS COMBINATION AGREEMENT by and among EDOC ACQUISITION CORP, as Purchaser, AMERICAN PHYSICIANS LLC, in the capacity as the Purchaser Representative, AUSTRALIAN OILSEEDS HOLDINGS LIMITED, as Pubco, AOI MERGER SUB, as Merger Sub, AUSTRALIAN OILSEEDS INVESTMENTS PTY LTD., as the Company, GARY SEATON in the capacity as the Seller Representative and THE |
|
| December 9, 2022 |
Exhibit 10.3 Execution Version Confidential SPONSOR SUPPORT AGREEMENT This SPONSOR SUPPORT AGREEMENT (this ?Agreement?) is made and entered into on as of December 5, 2022, by and among (i) American Physicians LLC, a Delaware limited liability company, (the ?Sponsor?) (ii) Edoc Acquisition Corp., a Cayman Islands exempted company (?Purchaser?), (iii) Australian Oilseeds Investments Pty Ltd., an Aus |
|
| December 9, 2022 |
Exhibit 10.2 Final Form FORM OF NON-COMPETITION AND NON-SOLICITATION AGREEMENT THIS NON-COMPETITION AND NON-SOLICITATION AGREEMENT (this ?Agreement?) is being executed and delivered as of December 5, 2022, by the undersigned security holder of the Company (as defined below) (the ?Subject Party?) in favor of and for the benefit of Australian Oilseeds Holdings Limited, upon execution of a joinder ag |
|
| December 9, 2022 |
Exhibit 10.3 Execution Version Confidential SPONSOR SUPPORT AGREEMENT This SPONSOR SUPPORT AGREEMENT (this ?Agreement?) is made and entered into on as of December 5, 2022, by and among (i) American Physicians LLC, a Delaware limited liability company, (the ?Sponsor?) (ii) Edoc Acquisition Corp., a Cayman Islands exempted company (?Purchaser?), (iii) Australian Oilseeds Investments Pty Ltd., an Aus |
|
| December 9, 2022 |
Exhibit 10.1 Final Form FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this ?Agreement?) is made and entered into as of December 5, 2022, by and among (i) Australian Oilseeds Holdings Limited, upon execution of a joinder agreement to become party to this Agreement (a ?Joinder?), a to-be-formed Cayman Islands exempted company (?Pubco?), (ii) American Physicians LLC, a Delaware limited liability |
|
| December 7, 2022 |
Exhibit 99.1 ~ Over the past 20 years, the Company has grown the business to be the largest cold pressing oil plant in Australia, pressing strictly GMO free conventional and organic oilseeds ~ ~ Combined company expected to have a post-transaction enterprise value of approximately $190 million ~ ~ The global oilseeds market is estimated at $264.87 billion in 2022 ~ ~ The oilseeds market is expecte |
|
| December 7, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 5, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| December 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 5, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| December 7, 2022 |
Exhibit 99.1 ~ Over the past 20 years, the Company has grown the business to be the largest cold pressing oil plant in Australia, pressing strictly GMO free conventional and organic oilseeds ~ ~ Combined company expected to have a post-transaction enterprise value of approximately $190 million ~ ~ The global oilseeds market is estimated at $264.87 billion in 2022 ~ ~ The oilseeds market is expecte |
|
| November 21, 2022 |
Exhibit 10.1 THIS PROMISSORY NOTE ("NOTE") HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| November 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 16, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39689 EDOC ACQUISI |
|
| October 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 12, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| October 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 6, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission F |
|
| October 12, 2022 |
Exhibit 10.1 THIS PROMISSORY NOTE (?NOTE?) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| October 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 3, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission F |
|
| August 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* EDOC Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) G4000A102 (CUSIP Number) August 25, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| August 31, 2022 |
SCHEDULE 13G CUSIP No. G4000A102 Page 11 of 11 Pages SCHEDULE 13G CUSIP No. G4000A102 Page 11 of 11 Pages EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Units of EDOC Acquisition Corp. dated as of August 31, 2022 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accorda |
|
| August 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 25, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission F |
|
| August 29, 2022 |
Exhibit 10.1 THIS PROMISSORY NOTE ("NOTE") HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| August 17, 2022 |
EDOC / Global X Telemedicine & Digital Health ETF / Meteora Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* EDOC Acquisition Corporation (Name of Issuer) Class A Ordinary share, $0.0001 par value (Title of Class of Securities) G4000A102 (CUSIP Number) February 28, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designat |
|
| August 15, 2022 |
Second Amended and Restated Memorandum and Articles of Association of the Company.(1) Exhibit 3.1 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF EDOC ACQUISITION CORP. (ADOPTED BY SPECIAL RESOLUTION PASSED ON 12 August 2022) THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES THIRD AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF EDOC ACQUISITION CORP. (A |
|
| August 15, 2022 |
EX-99.1 3 ea164374ex99-1edocacq.htm PRESS RELEASE, DATED AUGUST 15, 2022 Exhibit 99.1 EDOC Acquisition Corp. Announces Voting Results of Extraordinary General Meeting to Approve the Extension Amendment New York, NY – August 15, 2022 – EDOC Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, “EDOC” or the “Company”), a special purpose acquisition company, announced today that the Company’s shareholders |
|
| August 15, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 12, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission F |
|
| August 12, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 12, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission F |
|
| August 12, 2022 |
Edoc Acquisition Corp. Announces Termination of Merger Agreement with Calidi Biotherapeutics, Inc. Exhibit 99.1 Edoc Acquisition Corp. Announces Termination of Merger Agreement with Calidi Biotherapeutics, Inc. New York, NY ? August 12, 2022 ? Edoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, ?EDOC? or the ?Company?), a special purpose acquisition company, announced today the termination of its previously announced agreement and plan of merger (the ?Merger Agreement?) with Calidi Biotherapeut |
|
| August 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 12, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission F |
|
| August 12, 2022 |
Exhibit 99.1 Edoc Acquisition Corp. Announce Postponement of Special Meeting of Shareholders to Extend the Deadline to Consummate an Initial Business Combination ? Extraordinary General Meeting of Edoc?s shareholders postponed until August 12, 2022, at 8:00 p.m., Eastern Time NEW YORK, Aug. 12, 2022 (GLOBE NEWSWIRE) - Edoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, ?EDOC? or the ?Company?), to |
|
| August 4, 2022 |
Exhibit 99.1 Edoc Acquisition Corp. Reminds Shareholders to Vote and Announces Additional Contribution for Extension Amendment NEW YORK, August 4, 2022 ? Edoc Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, ?EDOC? or the ?Company?) encourages its shareholders to vote in favor of the proposal to amend its charter (the ?Extension Amendment?) to extend the date by which the Company has to complete a b |
|
| August 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| August 4, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 4, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fi |
|
| August 2, 2022 |
Filed by Calidi Biotherapeutics, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Form S-4 File No. 333-263628 Subject Company: Edoc Acquisition Corp. (Commission File No. 001-39689) Calidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial of NeuroNova in Patients with Recurrent High-Grade Glioma Calidi Biotherapeutics Announces FDA Authorization of IND for |
|
| August 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39689 EDOC ACQUISITION |
|
| July 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| July 25, 2022 |
PRER14A 1 ea163316-prer14aedocacq.htm PRELIMINARY PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Us |
|
| July 25, 2022 |
Edoc Acquisition Corp. 7612 Main Street Fisher, Suite 200 Victor, NY 14564 Edoc Acquisition Corp. 7612 Main Street Fisher, Suite 200 Victor, NY 14564 VIA EDGAR July 25, 2022 U.S. Securities & Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attn: Daniel Crawford Re: Edoc Acquisition Corp. Preliminary Proxy Statement on Schedule 14A Filed July 15, 2022 File No. 001-39689 Dear Mr. Crawford: Edoc Acquisition |
|
| July 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| June 28, 2022 |
425 1 ea162217-425calidibio.htm FORM 425 Filed by Calidi Biotherapeutics, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Form S-4 File No. 333-263628 Subject Company: Edoc Acquisition Corp. (Commission File No. 001-39689) Calidi Biotherapeutics Announces Appointment of W.K. Alfred Yung, M.D., to its Medical Advisory Board LA JOLLA, Calif. – June 28, 2022 – Calidi Biotherapeutics, Inc., |
|
| May 26, 2022 |
Exhibit 10.22 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of February 2, 2022, is by and among Edoc Acquisition Corp., a company organized under the laws of the Cayman Islands (the ?Company?), and the undersigned buyers (each, a ?Buyer,? and collectively, the ?Buyers?). RECITALS A. In connection with the Securities Purchase Agreement by and among t |
|
| May 26, 2022 |
Exhibit 10.29 form of REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of [?], 2022 is by and between [ ] (the ?Investor?), and [?] (f/k/a EDOC Acquisition Corp.), a Delaware corporation (the ?Company?). RECITALS A. The Company and the Investor have entered into that certain Common Stock Purchase Agreement, dated as of the date hereof (the ?Purchase Agr |
|
| May 26, 2022 |
Exhibit 10.28 COMMON STOCK PURCHASE AGREEMENT Dated as of March 16, 2022 by and between EDOC ACQUISITION CORP. and Tumim Stone Capital, LLC TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 2 ARTICLE II PURCHASE AND SALE OF COMMON STOCK 2 Section 2.1 Purchase and Sale of Stock 2 Section 2.2 Closing; Closing Date 2 Section 2.3 Initial Public Announcements and Required Filings 2 ARTICLE III PURCHASE TERM |
|
| May 26, 2022 |
As filed with the United States Securities and Exchange Commission May 25, 2022 As filed with the United States Securities and Exchange Commission May 25, 2022 Registration No. |
|
| May 26, 2022 |
Exhibit 10.30 FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT This First Amendment to Securities Purchase Agreement (the ?Agreement?) is entered into this 16th day of March, 2022, by and among Edoc Acquisition Corp., a company organized under the laws of the Cayman Islands with headquarters located at 7612 Main Street Fishers, Suite 200, Victor, New York (the ?Company?), and the investors listed |
|
| May 26, 2022 |
Exhibit 10.19 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of February 2, 2022, is by and among Edoc Acquisition Corp., a company organized under the laws of the Cayman Islands with headquarters located at 7612 Main Street Fishers, Suite 200, Victor, New York (the ?Company?), and each of the investors listed on the Schedule of Buyers attached hereto |
|
| May 25, 2022 |
Exhibit 99.2 is a clinical - stage biopharmaceutical company revolutionizing oncolytic viral therapies with stem cell - based platforms May 2022 This presentation contains forward - looking statements for purposes of the ?safe harbor? provisions under the United States Private Securities Litigation Reform Act of 1995. Terms such as ?anticipates,? ?believe,? ?continue,? ?could,? ?estimate,? ?expect |
|
| May 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 24, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission File |
|
| May 25, 2022 |
Exhibit 99.1 Calidi Biotherapeutics Granted US Patent for Proprietary Therapeutic Delivery Platform, Strengthening Company?s Intellectual Property Position in Immunotherapy LA JOLLA, Calif., May 24, 2022 ? Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company pioneering the development of stem cell-based delivery of oncolytic viruses, has been granted a new patent (No. US 11,285,194 |
|
| May 25, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 24, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission File |
|
| May 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 24, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission File |
|
| May 25, 2022 |
Exhibit 99.1 Calidi Biotherapeutics Granted US Patent for Proprietary Therapeutic Delivery Platform, Strengthening Company’s Intellectual Property Position in Immunotherapy LA JOLLA, Calif., May 24, 2022 — Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company pioneering the development of stem cell-based delivery of oncolytic viruses, has been granted a new patent (No. US 11,285,194 |
|
| May 25, 2022 |
Exhibit 2.1 SECOND AMENDMENT TO AGREEMENT AND PLAN OF MERGER This Second Amendment (?Second Amendment?) to the Merger Agreement (as defined below) is made and entered into as of May 24, 2022, by and among (i) Edoc Acquisition Corp., a Delaware corporation (together with its successors, the ?Purchaser?), (ii) Edoc Merger Sub Inc., a Nevada corporation and a wholly-owned subsidiary of the Purchaser |
|
| May 25, 2022 |
Exhibit 2.1 SECOND AMENDMENT TO AGREEMENT AND PLAN OF MERGER This Second Amendment (?Second Amendment?) to the Merger Agreement (as defined below) is made and entered into as of May 24, 2022, by and among (i) Edoc Acquisition Corp., a Delaware corporation (together with its successors, the ?Purchaser?), (ii) Edoc Merger Sub Inc., a Nevada corporation and a wholly-owned subsidiary of the Purchaser |
|
| May 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 24, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission File |
|
| May 25, 2022 |
Exhibit 99.2 is a clinical - stage biopharmaceutical company revolutionizing oncolytic viral therapies with stem cell - based platforms May 2022 This presentation contains forward - looking statements for purposes of the “safe harbor” provisions under the United States Private Securities Litigation Reform Act of 1995. Terms such as “anticipates,” “believe,” “continue,” “could,” “estimate,” “expect |
|
| May 24, 2022 |
Filed by Calidi Biotherapeutics, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Form S-4 File No. 333-263628 Subject Company: Edoc Acquisition Corp. (Commission File No. 333-263628) is a clinical - stage biopharmaceutical company revolutionizing oncolytic viral therapies with stem cell - based platforms May 2022 This presentation contains forward - looking statements for purposes of th |
|
| May 24, 2022 |
Filed by Calidi Biotherapeutics, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Form S-4 File No. 333-263573 Subject Company: Edoc Acquisition Corp. (Commission File No. 333-263628) Calidi Biotherapeutics Granted US Patent for Proprietary Therapeutic Delivery Platform, Strengthening Company?s Intellectual Property Position in Immunotherapy LA JOLLA, Calif., [May 24, 2022] ? Calidi Biot |
|
| May 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39689 EDOC ACQUISITION |
|
| April 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 14, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 17, 2022 |
Form of Common Stock Purchase Agreement.* Exhibit 10.14 COMMON STOCK PURCHASE AGREEMENT Dated as of March [ ], 2022 by and between EDOC ACQUISITION CORP. and [ ] TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 2 ARTICLE II PURCHASE AND SALE OF COMMON STOCK 2 Section 2.1 Purchase and Sale of Stock 2 Section 2.2 Closing; Closing Date 2 Section 2.3 Initial Public Announcements and Required Filings 2 ARTICLE III PURCHASE TERMS 3 Section 3.1 VWAP |
|
| March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 16, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 17, 2022 |
Form of First Amendment to Securities Purchase Agreement. Exhibit 10.1 FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT This First Amendment to Securities Purchase Agreement (the ?Agreement?) is entered into this 14th day of March, 2022, by and among Edoc Acquisition Corp., a company organized under the laws of the Cayman Islands with headquarters located at 7612 Main Street Fishers, Suite 200, Victor, New York (the ?Company?), and the investors listed o |
|
| March 17, 2022 |
As filed with the United States Securities and Exchange Commission March 16, 2022 Registration No. |
|
| March 17, 2022 |
Form of First Amendment to Securities Purchase Agreement. Exhibit 10.1 FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT This First Amendment to Securities Purchase Agreement (the ?Agreement?) is entered into this 14th day of March, 2022, by and among Edoc Acquisition Corp., a company organized under the laws of the Cayman Islands with headquarters located at 7612 Main Street Fishers, Suite 200, Victor, New York (the ?Company?), and the investors listed o |
|
| March 17, 2022 |
Form of Registration Rights Agreement.* Exhibit 10.15 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of [?], 2022 is by and between [ ] (the ?Investor?), and [?] (f/k/a EDOC Acquisition Corp.), a Delaware corporation (the ?Company?). RECITALS A. The Company and the Investor have entered into that certain Common Stock Purchase Agreement, dated as of the date hereof (the ?Purchase Agreement?) |
|
| March 17, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-4 (Form Type) EDOC ACQUISITION CORP. |
|
| March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 16, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4) * Edoc Acquisition Corp. (Name of Issuer) Common (Title of Class of Securities) G4000A102 (CUSIP Number) February 28, 2022 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| March 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39689 Edoc Acquisition |
|
| March 1, 2022 |
Joint Filing Agreement, by and between the Reporting Persons. Exhibit 99.1 JOINT FILING AGREEMENT AGREEMENT dated as of February 28, 2022 by and between American Physicians LLC, a Delaware limited liability company, and Xiaoping Becky Zhang (together, the ?Parties?). Each Party hereto represents to the other Party that it is eligible to use Schedule 13D to report its beneficial ownership of Class A ordinary shares, $0.0001 par value per share, of Edoc Acquis |
|
| March 1, 2022 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Edoc Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, $0.0001 par value (Title of Class of Securities) G4000A102 (CUSIP Number) Kevin Chen Chief Executive Officer 7612 Main Street Fishers, Suite 200 Victor, NY 14564 Telephone: (585) 678-1198 (Name, Address |
|
| February 15, 2022 |
Exhibit 2.1 FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER This First Amendment (“First Amendment”) to the Merger Agreement (as defined below) is made and entered into as of February 8, 2022, by and among (i) Edoc Acquisition Corp., a Delaware corporation (together with its successors, the “Purchaser”), (ii) Edoc Merger Sub Inc., a Nevada corporation and a wholly-owned subsidiary of the Purchaser |
|
| February 15, 2022 |
425 1 ea155125-8kedocacq.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 14, 2022 (February 8, 2022) EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 |
|
| February 15, 2022 |
Promissory Note of Edoc, dated February 13, 2022. Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| February 15, 2022 |
Amended and Restated Memorandum and Articles of Association of the Company Exhibit 3.1 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF EDOC ACQUISITION CORP. (adopted by special resolution passed on 9 FEBRUARY 2022) THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES SECOND AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF EDOC ACQUISITION CORP. |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) * Edoc Acquisition Corp. (Name of Issuer) Common (Title of Class of Securities) G4000A102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 14, 2022 |
Amended and Restated Memorandum and Articles of Association (8) EX-3.1 3 ea155125ex3-1edocacq.htm AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY Exhibit 3.1 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF EDOC ACQUISITION CORP. (adopted by special resolution passed on 9 FEBRUARY 2022) THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLA |
|
| February 14, 2022 |
Exhibit 2.1 FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER This First Amendment (“First Amendment”) to the Merger Agreement (as defined below) is made and entered into as of February 8, 2022, by and among (i) Edoc Acquisition Corp., a Delaware corporation (together with its successors, the “Purchaser”), (ii) Edoc Merger Sub Inc., a Nevada corporation and a wholly-owned subsidiary of the Purchaser |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 14, 2022 (February 8, 2022) EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorpo |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Edoc Acquisition Corp (Name of Issuer) Class A Ordinary Share, $0.0001 par value (Title of Class of Securities) G4000A102 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Edoc Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, $.0001 par value (Title of Class of Securities) G4000A102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 14, 2022 |
Promissory Note of Edoc Acquisition Corp., dated February 13, 2022. (8) EX-10.1 4 ea155125ex10-1edocacq.htm PROMISSORY NOTE OF EDOC, DATED FEBRUARY 13, 2022 Exhibit 10.1 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OP |
|
| February 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* Edoc Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $ 0.0001 (Title of Class of Securities) G4000A102 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 11, 2022 |
EDOC / Global X Telemedicine & Digital Health ETF / Weiss Asset Management LP Passive Investment =============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| February 7, 2022 |
Form of Certificate of Designations of Series A Convertible Stock. (7) EX-10.5 7 ea155021ex10-5edocacquisit.htm FORM OF CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK Exhibit 10.5 CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK OF [NEW NAME] (F/K/A EDOC ACQUISITION CORP.) I, [], hereby certify that I am the [] and [] of [NEW NAME] (F/K/A EDOC ACQUISITION CORP.) (the “Company”), a corporation organized and existing under the De |
|
| February 7, 2022 |
Form of Securities Purchase Agreement. (7) EX-10.3 5 ea155021ex10-3edocacquisit.htm FORM OF SECURITIES PURCHASE AGREEMENT Exhibit 10.3 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 2, 2022, is by and among Edoc Acquisition Corp., a company organized under the laws of the Cayman Islands with headquarters located at 7612 Main Street Fishers, Suite 200, Victor, New York (the “Company” |
|
| February 7, 2022 |
EX-99.1 2 ea154982ex99-1edocacq.htm PRESS RELEASE OF CALIDI BIOTHERAPEUTICS, INC, DATED FEBRUARY 4, 2022. Exhibit 99.1 Calidi Biotherapeutics Announces Appointment of Alfonso "Chito" Zulueta, Former President of International for Eli Lilly, to its Board of Directors LA JOLLA, CALIF (Feb. 4, 2022)- Calidi Biotherapeutics, Inc., a Nevada corporation (“Calidi”), is a clinical-stage biotechnology comp |
|
| February 7, 2022 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among EDOC ACQUISITION CORP., as the Purchaser, EDOC MERGER SUB INC, as Merger Sub, AMERICAN PHYSICIANS LLC in the capacity as the Purchaser Representative, ALLAN CAMAISA, in the capacity as the Seller Representative, and CALIDI BIOTHERAPEUTICS, INC., as the Company, Dated as of February 2, 2022 TABLE OF CONTENTS Page I. MERGER 2 1.1. Merger 2 1.2. T |
|
| February 7, 2022 |
Form of Registration Rights Agreement. (7) EX-10.6 8 ea155021ex10-6edocacquisit.htm FORM OF REGISTRATION RIGHTS AGREEMENT Exhibit 10.6 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 2, 2022, is by and among Edoc Acquisition Corp., a company organized under the laws of the Cayman Islands (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”). R |
|
| February 7, 2022 |
EX-10.4 6 ea155021ex10-4edocacquisit.htm FORM OF WARRANT Exhibit 10.4 [FORM OF WARRANT] NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR |
|
| February 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| February 7, 2022 |
Filed by Edoc Acquisition Corp. 425 1 ea155028-425edocacquicorp.htm FORM 425 Filed by Edoc Acquisition Corp. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: Edoc Acquisition Corp. Commission File No. 001-39689 Edoc Acquisition Corp. Reminds Shareholders to Vote in Favor of Extension Amendment NEW YORK, Feb. 07, 2022 (GLOBE NEWS |
|
| February 7, 2022 |
Exhibit 10.4 [FORM OF WARRANT] NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRAT |
|
| February 7, 2022 |
Exhibit 10.1 FORM OF VOTING AGREEMENT This Voting Agreement (this ?Agreement?) is made as of February 2, 2022 by and among (i) Edoc Acquisition Corp., a Cayman Islands exempted company (together with its successors, including its successor after the Conversion (as such term is defined in the Merger Agreement, as defined below), the ?Purchaser?), (ii) Calidi Biotherapeutics, Inc., a Nevada corporat |
|
| February 7, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 4, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| February 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 2, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorpor |
|
| February 7, 2022 |
Form of Certificate of Designations of Series A Convertible Preferred Stock EX-10.5 7 ea155021ex10-5edocacquisit.htm FORM OF CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK Exhibit 10.5 CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK OF [NEW NAME] (F/K/A EDOC ACQUISITION CORP.) I, [], hereby certify that I am the [] and [] of [NEW NAME] (F/K/A EDOC ACQUISITION CORP.) (the “Company”), a corporation organized and existing under the De |
|
| February 7, 2022 |
Form of Securities Purchase Agreement EX-10.3 5 ea155021ex10-3edocacquisit.htm FORM OF SECURITIES PURCHASE AGREEMENT Exhibit 10.3 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 2, 2022, is by and among Edoc Acquisition Corp., a company organized under the laws of the Cayman Islands with headquarters located at 7612 Main Street Fishers, Suite 200, Victor, New York (the “Company” |
|
| February 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 2, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorpor |
|
| February 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 4, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| February 7, 2022 |
EX-10.1 3 ea155021ex10-1edocacquisit.htm FORM OF VOTING AGREEMENT, DATED AS OF FEBRUARY 2, 2022, BY AND AMONG EDOC ACQUISITION CORP., CALIDI BIOTHERAPEUTICS, INC., AND THE STOCKHOLDERS OF CALIDI BIOTHERAPEUTICS, INC. PARTY THERETO Exhibit 10.1 FORM OF VOTING AGREEMENT This Voting Agreement (this “Agreement”) is made as of February 2, 2022 by and among (i) Edoc Acquisition Corp., a Cayman Islands e |
|
| February 7, 2022 |
EX-99.1 2 ea154982ex99-1edocacq.htm PRESS RELEASE OF CALIDI BIOTHERAPEUTICS, INC, DATED FEBRUARY 4, 2022. Exhibit 99.1 Calidi Biotherapeutics Announces Appointment of Alfonso "Chito" Zulueta, Former President of International for Eli Lilly, to its Board of Directors LA JOLLA, CALIF (Feb. 4, 2022)- Calidi Biotherapeutics, Inc., a Nevada corporation (“Calidi”), is a clinical-stage biotechnology comp |
|
| February 7, 2022 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among EDOC ACQUISITION CORP., as the Purchaser, EDOC MERGER SUB INC, as Merger Sub, AMERICAN PHYSICIANS LLC in the capacity as the Purchaser Representative, ALLAN CAMAISA, in the capacity as the Seller Representative, and CALIDI BIOTHERAPEUTICS, INC., as the Company, Dated as of February 2, 2022 TABLE OF CONTENTS Page I. MERGER 2 1.1. Merger 2 1.2. T |
|
| February 7, 2022 |
Form of Registration Rights Agreement EX-10.6 8 ea155021ex10-6edocacquisit.htm FORM OF REGISTRATION RIGHTS AGREEMENT Exhibit 10.6 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 2, 2022, is by and among Edoc Acquisition Corp., a company organized under the laws of the Cayman Islands (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”). R |
|
| February 7, 2022 |
EX-10.2 4 ea155021ex10-2edocacquisit.htm FORM OF LOCK-UP AGREEMENT, DATED AS OF FEBRUARY 2, 2022, BY AND AMONG EDOC ACQUISITION CORP Exhibit 10.2 Final Form FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of February 2, 2022 by and among (i) Edoc Acquisition Corp., a Cayman Islands exempted company, which will be known after the consummation of the t |
|
| February 7, 2022 |
Exhibit 10.2 Final Form FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this ?Agreement?) is made and entered into as of February 2, 2022 by and among (i) Edoc Acquisition Corp., a Cayman Islands exempted company, which will be known after the consummation of the transactions contemplated by the Merger Agreement (as defined below) as ?Calidi Biotherapeutics, Inc.? (including any successor entity |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2) ) ? Def |
|
| February 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 2, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| February 2, 2022 |
EX-99.1 4 ea154827ex99-1edocacq.htm PRESS RELEASE, DATED FEBRUARY 2, 2022 Exhibit 99.1 Calidi Biotherapeutics and Edoc Acquisition Corp. Agree to Merge and Create a Publicly Listed, Clinical-Stage Biotechnology Company Utilizing Stem Cell-Based Platforms to Revolutionize Oncolytic Virotherapies -Total gross proceeds from transaction expected to be approximately $117 million prior to redemptions, c |
|
| February 2, 2022 |
Form of Founder Share Transfer Agreement EX-10.8 3 ea154827ex10-8edocacq.htm FORM OF FOUNDER SHARE TRANSFER AGREEMENT Exhibit 10.8 SHARE TRANSFER AGREEMENT This Share Transfer Agreement (“Agreement”), dated February [], 2022, among [Investor Name], (each of [] and [] an “Investor”, and collectively the “Investors”) and American Physicians LLC (the “Sponsor”). RECITALS: A. EDOC Acquisition Corp., a Cayman Islands exempted company (the “ED |
|
| February 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 2, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| February 2, 2022 |
Exhibit 99.2 is a clinical - stage biopharmaceutical company u tilizing stem cell - based platforms to revolutionize oncolytic virotherapies February 2022 Investor Presentation Disclaimer This presentation (the ?Presentation?) is for informational purposes only with respect to the proposed business combination b etw een Edoc Acquisition Corp. (? Edoc ?) and Calidi Biotherapeutics, Inc. (together w |
|
| February 2, 2022 |
EX-99.2 5 ea154827ex99-2edocacq.htm INVESTOR PRESENTATION Exhibit 99.2 is a clinical - stage biopharmaceutical company u tilizing stem cell - based platforms to revolutionize oncolytic virotherapies February 2022 Investor Presentation Disclaimer This presentation (the “Presentation”) is for informational purposes only with respect to the proposed business combination b etw een Edoc Acquisition Cor |
|
| February 2, 2022 |
Form of Forward Purchase Agreement Exhibit 10.7 FORWARD SHARE PURCHASE AGREEMENT This Forward Share Purchase Agreement (this “Agreement”) is entered into as of February [], 2022, by and among (i) Edoc Acquisition Corp Inc., a Cayman Islands exempted company (“EDOC”), (ii) [Investor Name], and (iii) [Investor Name] (“[]” and together with [], each individually an “Investor” and collectively, the “Investors”). Each of EDOC, [] and [] |
|
| February 2, 2022 |
Form of Forward Purchase Agreement Exhibit 10.7 FORWARD SHARE PURCHASE AGREEMENT This Forward Share Purchase Agreement (this ?Agreement?) is entered into as of February [], 2022, by and among (i) Edoc Acquisition Corp Inc., a Cayman Islands exempted company (?EDOC?), (ii) [Investor Name], and (iii) [Investor Name] (?[]? and together with [], each individually an ?Investor? and collectively, the ?Investors?). Each of EDOC, [] and [] |
|
| February 2, 2022 |
Form of Founder Share Transfer Agreement EX-10.8 3 ea154827ex10-8edocacq.htm FORM OF FOUNDER SHARE TRANSFER AGREEMENT Exhibit 10.8 SHARE TRANSFER AGREEMENT This Share Transfer Agreement (“Agreement”), dated February [], 2022, among [Investor Name], (each of [] and [] an “Investor”, and collectively the “Investors”) and American Physicians LLC (the “Sponsor”). RECITALS: A. EDOC Acquisition Corp., a Cayman Islands exempted company (the “ED |
|
| February 2, 2022 |
EX-99.1 4 ea154827ex99-1edocacq.htm PRESS RELEASE, DATED FEBRUARY 2, 2022 Exhibit 99.1 Calidi Biotherapeutics and Edoc Acquisition Corp. Agree to Merge and Create a Publicly Listed, Clinical-Stage Biotechnology Company Utilizing Stem Cell-Based Platforms to Revolutionize Oncolytic Virotherapies -Total gross proceeds from transaction expected to be approximately $117 million prior to redemptions, c |
|
| January 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| January 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment 1 (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39689 ED |
|
| January 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment 1 (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39689 EDO |
|
| January 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment 1 (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-3968 |
|
| January 14, 2022 |
Exhibit 10.18 January 14, 2022 Edoc Acquisition Corp. 7612 Main Street Fishers Suite 200 Victor, NY 14564 Attention: Christine Zhao I-Bankers Securities, Inc. 535 5th Ave Suite 423 New York, New York 10017 Attention: Mike McCrory Dear Ms. Zhao and Mr. McCrory: Reference is made to the Letter Agreement, dated November 9, 2020 (the ?Letter Agreement?) by and among Edoc Acquisition Corp., a Cayman Is |
|
| January 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Amendment No. 1) (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39689 |
|
| January 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| January 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 11, 2022 EDOC Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-39689 N/A (State or other jurisdiction of incorporation) (Commission |
|
| January 11, 2022 |
OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number:3235-0145 Expires:Febuary 28, 2009 Estimated average burden hours per response ....10.4 SCHEDULE 13G Under the Securities and Exchange Act of 1934 (Amendment No. 1 )* EDOC Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $ 0.0001 (Title of Class of Securities) G4000A102 (CUSIP Numbe |
